According to ResMed's latest financial reports the company's current EPS (TTM) is 5,41 โฌ. In 2022 the company made an earnings per share (EPS) of 4,85 โฌ an increase over its 2021 EPS that were of 3,14 โฌ.
Year | EPS | Change |
---|---|---|
2023 (TTM) | 5,72 โฌ | 17.94% |
2022 | 4,85 โฌ | 54.19% |
2021 | 3,14 โฌ | -25.88% |
2020 | 4,24 โฌ | 52.37% |
2019 | 2,78 โฌ | 0.63% |
2018 | 2,77 โฌ | 55.94% |
2017 | 1,77 โฌ | -12.17% |
2016 | 2,02 โฌ | -7.63% |
2015 | 2,19 โฌ | -0.4% |
2014 | 2,20 โฌ | 9.65% |
2013 | 2,00 โฌ | 12.32% |
2012 | 1,78 โฌ | -10.18% |
2011 | 1,98 โฌ | 58.6% |
2010 | 1,25 โฌ | 23.91% |
2009 | 1,01 โฌ | 44.65% |
2008 | 0,70 โฌ | 96.3% |
2007 | 0,36 โฌ | -41.3% |
2006 | 0,61 โฌ | 35.29% |
2005 | 0,45 โฌ | 9.68% |
2004 | 0,41 โฌ | 20% |
2003 | 0,34 โฌ | 27.05% |
2002 | 0,27 โฌ | 159.57% |
2001 | 0,10 โฌ | -43.37% |
2000 | 0,18 โฌ | 31.07% |
1999 | 0,14 โฌ | 45.05% |
1998 | 0,09586 โฌ | 54.24% |
1997 | 0,06215 โฌ | 28.26% |
1996 | 0,04845 โฌ |